HAVRIX
Biological
GlaxoSmithKline, LLC.
Total Payments
$59,309
Transactions
70
Doctors
58
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $41,564 | 27 | 18 |
| 2019 | $52.82 | 4 | 4 |
| 2018 | $17,211 | 8 | 5 |
| 2017 | $482.00 | 31 | 31 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $49,980 | 11 | 84.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,679 | 16 | 14.6% |
| Food and Beverage | $650.58 | 43 | 1.1% |
Payments by Type
Research
$49,980
11 transactions
General
$9,329
59 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MMR-160 | GlaxoSmithKline, LLC. | $49,980 | 0 |
Top Doctors Receiving Payments for HAVRIX — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Toledo, OH | $12.33 | 1 |
| Manish Chheda | Internal Medicine | Greenfield, IN | $12.32 | 1 |
| , DO | Internal Medicine | York, PA | $11.74 | 1 |
| , DO | Family Medicine | York, PA | $11.74 | 1 |
| , DO | Internal Medicine | York, PA | $11.74 | 1 |
| , MD | Internal Medicine | Hagerstown, MD | $11.16 | 1 |
| , MD | Rheumatology | Cumberland, MD | $11.16 | 1 |
| , M.D | Family Medicine | Johnson City, TN | $8.36 | 1 |
| , M.D | Family Medicine | Johnson City, TN | $8.35 | 1 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $59,309
Product Information
- Type Biological
- Total Payments $59,309
- Total Doctors 58
- Transactions 70
About HAVRIX
HAVRIX is a biological associated with $59,309 in payments to 58 healthcare providers, recorded across 70 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2017 to 2020. In 2020, $41,564 was paid across 27 transactions to 18 doctors.
The most common payment nature for HAVRIX is "Unspecified" ($49,980, 84.3% of total).
HAVRIX is associated with 1 research study, including "MMR-160" ($49,980).